Expertise in
14
conditions

Dr. John K. Botson

Rheumatology
Orthoalaska LLC
3801 Lake Otis Pkwy, Suite 300, 
Anchorage, AK 
 (3096.3 mi)
Accepting New Patients
Offers Telehealth
21 Years of Experience
Expertise in
14
conditions
Orthoalaska LLC
3801 Lake Otis Pkwy, Suite 300, 
Anchorage, AK 
 (3096.3 mi)
OverviewInsuranceLocationsClinical Research

Overview

John Botson is a Rheumatologist in Anchorage, Alaska. Dr. Botson has been practicing medicine for over 21 years is highly rated in 14 conditions, according to our data. His top areas of expertise are Gout, Rheumatoid Arthritis (RA), Raynaud Phenomenon, and Arthritis. Dr. Botson is currently accepting new patients.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2004
Specialties
Rheumatology
Licenses
Internal Medicine in AK
Hospital Affiliations
Central Peninsula General Hospital
Providence Alaska Medical Center
Mat-Su Regional Medical Center
Providence Seward Hospital
Languages Spoken
English
Castilian
Hindi
Kannada
Russian
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Premera
  •  Moda Health
  •  HMSA

Locations

ORTHOALASKA LLC
3801 Lake Otis Pkwy, Suite 300, Anchorage, AK 99508
Other Locations
RHEUMATOLOGY ASSOCIATES OF MAUI LLC
161 Wailea Ike Pl, Suite A104, Kihei, HI 96753

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Enrollment Status: Completed
Publish Date: January 07, 2025
Intervention Type: Biological
Study Drugs: Pegloticase, MTX
Study Phase: Phase 4
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Biological, Drug
Study Drugs: Pegloticase, Methotrexate
Study Phase: Phase 4
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological, Drug, Dietary supplement
Study Phase: Phase 4
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
View 3 Less Clinical Trials

15 Total Publications

Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open-Label Trial.
Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open-Label Trial.
Journal: ACR open rheumatology
Published: August 19, 2024
Similar Doctors
Expertise in
10
conditions
Dr. Elizabeth D. Ferucci
Rheumatology
Expertise in
10
conditions
Dr. Elizabeth D. Ferucci
Rheumatology

Alaska Native Tribal Health Consortium

3900 Ambassador Dr, 
Anchorage, AK 
 (1.0 mi)
907-563-2662
Languages Spoken:
English, Filipino, Romanian, Spanish, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Elizabeth Ferucci is a Rheumatologist in Anchorage, Alaska. Dr. Ferucci is highly rated in 10 conditions, according to our data. Her top areas of expertise are Mixed Connective Tissue Disease, Rheumatoid Arthritis (RA), Neurosarcoidosis, and Sarcoidosis. Dr. Ferucci is currently accepting new patients.

Expertise in
9
conditions
Dr. Ryan L. Ragle
Rheumatology
Expertise in
9
conditions
Dr. Ryan L. Ragle
Rheumatology

Orthoalaska LLC

3801 Lake Otis Pkwy, Suite 300, 
Anchorage, AK 
907-562-2277
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ryan Ragle is a Rheumatologist in Anchorage, Alaska. Dr. Ragle is highly rated in 9 conditions, according to our data. His top areas of expertise are Raynaud Phenomenon, Granulomatosis with Polyangiitis, Scleroderma, and Systemic Sclerosis (SSc). Dr. Ragle is currently accepting new patients.

Expertise in
8
conditions
Dr. Vivek R. Mehta
Rheumatology
Expertise in
8
conditions
Dr. Vivek R. Mehta
Rheumatology

Alaska Native Tribal Health Consortium

4315 Diplomacy Dr, 
Anchorage, AK 
 (1.2 mi)
907-563-2662
Experience:
12+ years
Languages Spoken:
English, Hindi, Italian, Japanese, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Vivek Mehta is a Rheumatologist in Anchorage, Alaska. Dr. Mehta has been practicing medicine for over 12 years is highly rated in 8 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Rheumatoid Vasculitis, Ankylosing Spondylitis, and Axial Spondyloarthritis (AxSpA). Dr. Mehta is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile